Biological Materials Availability: Dated: February 22, 2007. www.ni.gov/od/oar/index.htm, where an
Biological materials related to this Steven M. Ferguson, agenda and any additional information for technology are not available at this time. the meeting will be posted when available. Director, Division of Technology Development Licensing Availability: This and Transfer, Office of Technology Transfer, (Catalogue of Federal Domestic Assistance application is available for license on a National Institutes of Health. Program Nos. 93.14, Intramural Research non-exclusive or exclusive basis. [FR Doc. E7–3695 Filed 3–1–07; 8:45 am] Training Award; 93.22, Clinical Research Licensing Contact: Susan S. Rucker; Loan Repayment Program for Individuals BILLING CODE 4140–01–P 301/435–4478; e-mail: from Disadvantaged Backgrounds; 93.232, ruckersu@mail.nih.gov. Loan Repayment Program for Research Generally; 93.39, Academic Research DEPARTMENT OF HEALTH AND Enhancement Award; 93.936, NIH Acquired Genes Expressed in Prostate Cancer HUMAN SERVICES Immunodeficiency Syndrome Research Loan and Methods of Use Repayment Program; 93.187, Undergraduate Description of Technology: This National Institutes of Health Scholarship Program for Individuals from invention is a novel gene, called New Disadvantaged Backgrounds, National Gene Expressed in Prostate (NGEP). Office of the Director, National Institutes of Health, HHS) This gene appears to be expressed only Institutes of Health; Notice of Meeting Dated: February 23, 2007. in human prostate and prostate cancer. Pursuant to section 10(a) of the Anna Snouffer, This gene has two known splice variants Federal Advisory Committee Act, as Acting Director, Office of Federal Advisory of significantly different size. The amended (5 U.S.C. Appendix 2), notice Committee Policy. shorter splice variant encodes a is hereby given of a meeting of the [FR Doc. 07–961 Filed 3–1–07; 8:45 am] cytoplasmic protein, while the longer Office of AIDS Research Advisory BILLING CODE 4140–01–M splice variant encodes a plasma Council. membrane protein, which has been The meeting will be open to the detected on the plasma membrane of public, with attendance limited to space DEPARTMENT OF HEALTH AND human cancer cells. available. Individuals who plan to HUMAN SERVICES This patent application contains attend and need special assistance, such claims to the polypeptide, NGEP, as sign language interpretation or other National Institutes of Health nucleotides encoding NGEP, antibodies reasonable accommodations, should that bind NGEP polypeptides, and notify the Contact Person listed below Notice of Meeting: Secretary’s methods of using these polypeptides, in advance of the meeting. Advisory Committee on Genetics, polynucleotides, and antibodies. Health, and Society The presence of the protein on the Name of Committee: Office of AIDS cell surface and the selective expression Research Advisory Council. Pursuant to Public Law 92–463, Date: April 19, 2007. notice is hereby given of the twelfth in prostate and prostate cancer make Time: 9 a.m. to 5 p.m. this a potential target for prostate cancer meeting of the Secretary’s Advisory Agenda: The meeting will focus on HIV- Committee on Genetics, Health, and diagnostics and therapeutics. Potential related Complications including therapeutics could be gene-based, Society (SACGHS), U.S. Public Health Malignancies, Cardiovascular Disease, and vaccines, antibodies, or Metabolic Complications. An update will be Service. The meeting will be held from immunoconjugates. provided on the OARAC Working Groups for 8 a.m. to approximately 5 p.m. on Inventors: Ira Pastan, Tapan Bera, and Treatment and Prevention Guidelines. Monday, March 26, 2007 and 8 a.m. to Byungkook Lee (NCI.) Place: National Institutes of Health, 5635 approximately 5 p.m. on Tuesday, Publications: Fishers Lane, Rockville, MD 20852. March 27, 2007, at the Marriott Inn and 1. S Das et al. NGEP, a prostate- Contact Person: Christina Brackna, Conference Center, University of Coordinator, Program Planning and Analysis, Maryland—College Park, 3501 specific plasma membrane protein that Office of Aids Research, Office of the promotes the association of LNCaP cells. University Boulevard East, Adelphi, MD Director, NIH, 5635 Fishers Lane MSC 9310, Cancer Res. 2007 Feb 15; 67(4):1594– 20783. The meeting will be open to the Suite 4000, Rockville, MD 20852, (301) 402– 1601. 8655, cm53v@nih.gov. public with attendance limited to space 2. TK Bera et al. NGEP, a gene Any member of the public interested in available. The meeting also will be Web encoding a membrane protein detected presenting oral comments to the committee cast. only in prostate cancer and normal may notify the Contact Person listed on this The agenda will focus on the prostate. Proc Natl Acad Sci USA. 2004 notice at least 10 days in advance of the oversight of genetic testing, including Mar 2; 101(9):3050–3064. meeting. Interested individuals and the role of the private sector in assuring Patent Status: representatives of organizations may submit the quality and validity of genetic tests; a letter of intent, a brief description of the the impact of gene patents and licensing 1. U.S. Provisional Application No. organization represented, and a short 60/461,399 filed 08 Apr 2003 (HHS practices on patient access to genetic description of the oral presentation. Only one Reference No. E–148–2003/0–US–01). representative of an organization may be technologies, including a progress 2. PCT Application No. PCT/US04/ allowed to present oral comments and if report on the Committee’s study; and 10588 filed 05 Apr 2004, which accepted by the committee, presentations the status of Federal genetic information published as WO 2004/092213 on 28 may be limited to five minutes. Both printed nondiscrimination legislation. The Oct 2004 (HHS Reference No. E–148– and electronic copies are requested for the Committee will be briefed on the 2003/0–PCT–02). record. In addition, any interested person Secretary’s Personalized Health Care 3. U.S. Patent Application No. 10/ may file written comments with the Initiative and the work of the American 552,515 filed 06 Oct 2005 (HHS committee by forwarding their statement to Health Information Community, the Contact Person listed on this notice. The particularly its Personalized Health Care Reference No. E–148–2003/0–US–03). pwalker on PROD1PC71 with NOTICES
statement should include the name, address,
Licensing Status: Available for non- telephone number and when applicable, the Working Group. The Committee’s report exclusive licensing. business or professional affiliation of the on the Policy Issues Associated with Licensing Contact: Jesse S. Kindra, interested person. Undertaking a New Large U.S. J.D.; 301/435–5559; Information is also available on the Population Cohort Project on Genes, kindraj@mail.nih.gov. Institute’s Center’s home page: http:// Environment and Disease will be
VerDate Aug<31>2005 18:44 Mar 01, 2007 Jkt 211001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1